New evidence COVID-19 antibodies, vaccines less effective against variants | The Source

Worrisome new coronavirus variants can evade antibodies that neutralize original virus
Physician assistant Philana Liang prepares a vial of COVID-19 vaccine on the Washington University Medical Campus. New research from Washington University School of Medicine in St. Louis has found that new variants of the virus that causes COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic, potentially undermining the effectiveness of vaccines and antibody-based drugs now being used to prevent or treat COVID-19. (Photo: Matt Miller/School of Medicine)
March 4, 2021
SHARE
New research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus that causes COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic. With few exceptions, whether such antibodies were produced in response to vaccination or natural infection, or were purified antibodies intended for use as drugs, the researchers found more antibody is needed to neutralize the new variants

Related Keywords

South Africa ,United Kingdom ,Brazil ,Ali Ellebedy ,Pei Yong Shi ,Xianwen Zhang ,Herberts Gasser ,Ritae Chen ,Pfizer ,Washington University ,Drug Administration ,Washington University School Of Medicine ,University Of Texas Medical Branch ,Johnson ,Washington University School ,Nature Medicine ,Texas Medical ,ஒன்றுபட்டது கிஂக்டம் ,பிரேசில் ,பேய் யோங் ஷி ,ஹெர்பர்ட்ஸ் காஸர் ,ஃபைசர் ,வாஷிங்டன் பல்கலைக்கழகம் ,வாஷிங்டன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து ,பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் மருத்துவ கிளை ,ஜான்சன் ,வாஷிங்டன் பல்கலைக்கழகம் பள்ளி ,இயற்கை மருந்து ,டெக்சாஸ் மருத்துவ ,